The present disclosure pertains to medical devices, and methods for manufacturing medical devices. More particularly, the present disclosure pertains to filtration devices usable in processing biological samples.
A wide variety of medical devices have been developed for medical use, for example for collecting and/or processing biological samples. Some of these devices include filtration devices.
This disclosure provides design, material, manufacturing method, and use alternatives for medical devices. An example medical device includes a cell filtration assembly that is adapted to capture cells from a biological sample during centrifugation. The cell filtration assembly includes a filter support member including a sample well and a filter membrane spanning the sample well, where the filter support member and/or the filter membrane adapted to be sectioned. A protective element is disposed over at least a portion of the filter support member and is adapted to protect the filter support member from tissue processing reagents during processing of the cells captured from the biological sample.
A cell filtration assembly is disclosed. The cell filtration assembly comprises: a filter support member including a sample well; a filter membrane extending across the sample well; the filter support member and/or the filter membrane configured to be sectioned; and a protective element disposed over at least a portion of the filter support member, the protective element configured to protect the filter support member from tissue processing reagents during processing of the cells captured from the biological sample.
Alternatively or additionally to any of the embodiments above, the protective element is adapted to be removed prior to sectioning.
Alternatively or additionally to any of the embodiments above, the protective element includes a removable shell.
Alternatively or additionally to any of the embodiments above, the protective element is adapted to be sectioned while disposed over at least a portion of the filter support member.
Alternatively or additionally to any of the embodiments above, the protective element includes a polymeric coating.
Alternatively or additionally to any of the embodiments above, the protective element includes Parylene.
Alternatively or additionally to any of the embodiments above, the filter support member includes a material that is at least partially miscible in xylene.
Alternatively or additionally to any of the embodiments above, the filter support member includes a wax.
Alternatively or additionally to any of the embodiments above, the filter support member includes paraffin.
Another example medical device is a cell filtration assembly that is adapted to capture cells from a biological sample. The cell filtration assembly includes a sectionable base member and a sample well that is defined within the sectionable base member. A porous surface defines a lower portion of the sample well and is adapted to capture cells from the biological sample while permitting fluids to pass therethrough during centrifugation. A protective polymeric coating is disposed over at least a portion of the sectionable base member and protects the sectionable base member against tissue processing reagents. The protective polymer coating is sectionable.
Alternatively or additionally to any of the embodiments above, the protective polymer coating includes Parylene.
Alternatively or additionally to any of the embodiments above, the sectionable base member includes a material that is at least partially miscible in xylene.
Alternatively or additionally to any of the embodiments above, the sectionable base member includes a wax.
Alternatively or additionally to any of the embodiments above, the sectionable base member includes paraffin.
Alternatively or additionally to any of the embodiments above, the porous surface has an average pore size of about 0.1 to 50 micrometers.
Alternatively or additionally to any of the embodiments above, the porous surface has an average pore size of about 2 to 10 micrometers.
Another example medical device is a cell filtration assembly that is adapted to capture cells from a biological sample. The cell filtration assembly includes a sectionable base member, a sample well defined within the sectionable base member and a porous surface that defines a lower portion of the sample well and is adapted to capture cells from the biological sample while permitting fluids to pass therethrough during centrifugation. A protective shell is disposed over at least a portion of the sectionable base member and protects the sectionable base member against tissue processing reagents. The protective shell is removable prior to sectioning the sectionable base member.
Alternatively or additionally to any of the embodiments above, the cell filtration assembly further includes a protective cap that protects at least some portions of the sectionable base member that are not protected by the protective shell.
Alternatively or additionally to any of the embodiments above, the cell filtration assembly further includes a protective membrane that is securable to a lower surface of the sectionable base member to protect the lower surface of the sectionable base member against tissue processing reagents.
Alternatively or additionally to any of the embodiments above, the sectionable base member includes paraffin.
The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present disclosure. The Figures, and Detailed Description, which follow, more particularly exemplify these embodiments.
The disclosure may be more completely understood in consideration of the following detailed description in connection with the accompanying drawings, in which:
While the disclosure is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the disclosure to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure.
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about”, whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (e.g., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.
The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
It is noted that references in the specification to “an embodiment”, “some embodiments”, “other embodiments”, etc., indicate that the embodiment described may include one or more particular features, structures, and/or characteristics. However, such recitations do not necessarily mean that all embodiments include the particular features, structures, and/or characteristics. Additionally, when particular features, structures, and/or characteristics are described in connection with one embodiment, it should be understood that such features, structures, and/or characteristics may also be used connection with other embodiments whether or not explicitly described unless clearly stated to the contrary.
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the disclosure.
There are a number of methods for the collection of biological samples by a biopsy and/or other surgical processes. Such processes typically result in a tissue sample that can be routinely processed for pathological analysis. In some endoscopic procedures such as those where a fine needle aspiration device is utilized, the sample that is collected includes loose cells and fluids. Prior to tissue processing and/or analysis, additional steps may be necessary to gather the desired cells/tissue and allow the cells/tissue to be further processed. Disclosed herein are devices and methods that allow cells/tissue to be efficiently processed and/or analyzed including cells/tissue gathered by fine needle aspiration devices and/or other devices that collect cells/tissue along with fluids. In some cases, for example, the devices and methods described herein may be used in processing cells, tissue or other biological samples obtained using other techniques as well.
In some cases, a biological sample including cells or other tissue within a fluid may be subjected to centrifugation in order to collect the cells or other tissue on a substrate for subsequent processing and examination while eliminating the fluid that previously carried the cells or other tissue. Once the cells are captured on a substrate such as but not limited to a filter membrane, they may be treated with other reagents, fixing agents, and the like, during tissue processing. The cells may subsequently be embedded in a medium, such as but not limited to a wax such as paraffin wax. In some cases, the cells embedded in a medium may be referred to as a cell block. The cell block may subsequently be sectioned into thin slices for mounting on a glass slide for analysis on a microscope, for example, or sliced from the cell block for other analytical processes. For example, visualization of the cells and the extracellular environment can provide information to determine whether the tissue collected is benign or malignant. Alternatively, the slices provide cellular material (DNA, RNA, proteins) for microcellular analysis.
In some cases, a biological sample may be initially processed by placing the biological sample, which typically includes cells or other tissue of interest, within a fluid, into a centrifuge tube and spinning or otherwise centrifuging the biological sample in order to capture the cells or other tissue of interest on a substrate such as a filter membrane while driving off the extraneous fluid. In some cases, the centrifuge tube may include a fixative, which refers to a compound that helps to preserve the cells or other tissue of interest. Illustrative but non-limiting examples of suitable fixatives include formalin, ethanol and methanol. In some cases, saline may be included as a holding solution. Another example is RPMI medium, or Rosewell Park Memorial Institute medium, which is a medium used in cell culture and tissue culture. In some cases, a centrifuge tube may have a volume ranging from about 15 milliliters (ml) to about 50 ml, although this is merely illustrative. In some instances, the centrifuge tube may accommodate a filter membrane upon which the cells or other tissue of interest may be collected, as will be discussed subsequently. The centrifuge tube may be spun in a standard centrifuge at speeds that subject the contents of the centrifuge tube to relative centrifugal forces (RCF) of between about 200 to about 1800 RCF.
A filter membrane 16 extends across a lower end (in the illustrated orientation) of the sample well 14. It will be appreciated that the filter support member 12 and/or the filter membrane 16 may be configured to be sectioned. In some cases, the filter membrane 16 may be considered as being a porous surface that defines a lower portion of the sample well 14. A protective element 18 may be disposed over at least a portion of the filter support member 12 and may, for example, be adapted to protect the filter support member 12 or at least portions thereof from tissue processing reagents during processing of the cells captured from the biological sample. In some cases, the filter membrane 16 may include a porous material with openings sized to allow the desired cells/tissue to be collected thereon while allowing fluids to pass therethrough. For example, the filter membrane 16 have pores that are about 0.1-50 micrometers, or about 1-20 micrometers, or about 2-10 micrometers, or about 5 micrometers, or smaller than about 10 micrometers, or smaller than about 5 micrometers, or the like.
In some cases, the protective element 18 may be configured to remain disposed on at least a portion of the filter support member 12, and may in fact be configured to subsequently be sectioned along with the filter support member 12 and/or the filter membrane 16 (and the cells or other tissue of interest disposed on the filter membrane 16).
In some cases, the protective element 18 (
In
It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the disclosure. This may include, to the extent that it is appropriate, the use of any of the features of one example embodiment being used in other embodiments. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
This application claims priority under 35 U.S.C. § 119 to U.S. Provisional Application Ser. No. 62/527,447, filed Jun. 30, 3017, the entirety of which is incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
62527447 | Jun 2017 | US |